ID
43569
Description
Study ID: 101468/197 Clinical Study ID: SKF-101468/197 Study Title:An open study to compare the PK and tolerability of ropinirole administered as 5 different new formulations with the standard, marketed formulation in healthy volunteers Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Requip Study Indication : Restless Legs Syndrome
Keywords
Versions (3)
- 9/11/17 9/11/17 -
- 9/12/17 9/12/17 -
- 9/20/21 9/20/21 -
Uploaded on
September 20, 2021
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
visit period 1,2,3 & 4 plasma drug assay PK and tolerability of ropinirole as 5 new formulations 101468/197
visit period 1,2,3 & 4 plasma drug assay PK and tolerability of ropinirole as 5 new formulations 101468/197
Description
Date and Time
Alias
- UMLS CUI-1
- C1264639
Description
plasma assay sample
Alias
- UMLS CUI-1
- C0444263
- UMLS CUI-3
- C0013227
- UMLS CUI-4
- C0683150
Description
time relative to dosing
Data type
text
Alias
- UMLS CUI [1,1]
- C0439564
- UMLS CUI [1,2]
- C3469597
- UMLS CUI [1,3]
- C0304229
Description
date
Data type
date
Alias
- UMLS CUI [1]
- C0011008
Description
time
Data type
time
Alias
- UMLS CUI [1]
- C0040223
Description
comment
Data type
text
Alias
- UMLS CUI [1]
- C0947611
Description
initials
Data type
text
Alias
- UMLS CUI [1]
- C2986440
Similar models
visit period 1,2,3 & 4 plasma drug assay PK and tolerability of ropinirole as 5 new formulations 101468/197
C3469597 (UMLS CUI [2])
C0013227 (UMLS CUI-3)
C0683150 (UMLS CUI-4)
C3469597 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,3])
No comments